Dr. Robert Orlowski is the Featured Speaker on The Cure Panel Talk Show on April 25 @ 6pm EST

***Now that this program has aired you can listen to the rebroadcast of this very patient friendly presentation on “Exciting New Drugs and Combinations for Myeloma” if you CLICK HERE.***

Picture

Fresh from the Myeloma International  Workshop in Kyoto, Japan, Dr. Orlowski will be the featured speaker on the Myeloma Cure Panel Broadcast on April 25 at 6PM EST.  

Dr. Robert Z. Orlowski, MD, PhD is Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics, Division of Cancer Medicine, at The University of Texas M.D. Anderson Cancer Center in Houston, Texas. He is board-certified in internal medicine and medical oncology. Dr. Orlowski earned his doctoral degree in molecular biophysics and biochemistry from Yale University and his medical degree from the Yale University School of Medicine. Dr. Orlowski has published numerous book chapters, articles, and abstracts on cancer therapy, with a focus on the molecular pathogenesis of oncologic disease processes and the mechanisms of action of chemotherapeutics. His clinical research efforts focus on the translation of promising laboratory based findings into novel clinical trials for patients with hematologic malignancies. He has published in, and is a reviewer for, several journals,including Blood, Cancer Research, Journal of Clinical Oncology, and the New England Journal of Medicine. He has received several awards, including The Leukemia & Lymphoma Society Scholar in Clinical Research and the Jefferson-Pilot Fellowship in Academic Medicine.

M. D. Anderson is one of the most famous cancer centers in the world, and Dr. Orlowski is one of the worlds most renowned multiple myeloma specialists.  I am sure he will be bringing  back the latest news from the Kyoto meetings.  Please join me and the rest of the Cure Talk Panel where patients will have an opportunity to ask Dr. Orlowski questions that they would like an expect to answer.  You can still sign up for a the few remaining spots that are available if you CLICK HERE!